Page 4 - Axio Biosolutions News Today

Kochi: Axio Biosolutions, a medical tech company headquartered in Bengaluru under Malayali entrepreneur Leo Maveli, rolled out a grand presentation to the employees. According to the Employees Stock Option Plan (ESOP), the company rendered Rs 3.75 crore

Bangalore-based Axio Biosolutions announces ESOP buyback program

On Monday, various start-ups announced ESOP buybacks, with employees being able to vest their shares at a much higher value

India, United States, Israel Should Pursue a Defense Innovation Triad

Paytms board games SUBSCRIBE Thank you for subscribing to Morning Dispatch Well soon meet in your inbox. / Morning Dispatch Paytm, which plans to go public in a few months, has agreed to give its founder Vijay Shekhar Sharma the right to appoint one member to its board. The agreement, which is subject to Sharma meeting certain conditions, must first be approved by shareholders. Also in this letter: WazirX to launch decentralised exchange Paytm’s Sharma can appoint one board member Paytm CEO...

Latest research on Global Wound Care Market report covers forecast and analysis on a worldwide, regional and country level. The study provides historical information of 2016-2021 together with a forecast from 2021 to 2026 supported by both volume and revenue (USD million). The entire study covers the key drivers and restraints for the Wound Care market. this report included a special section on the Impact of COVID19. Also, Wound Care Market (By major Key Players, By Types, By Applications, a...

Axio Biosolutions receives CE Certification for next gen wound-care product MaxioCel Axio Biosolutions receives CE Certification for next gen wound-care product MaxioCel 05 February 2021 | News This next-generation advanced wound-care dressing, MaxioCel is based on Bioactive Microfiber Gelling technology that accelerates healing through quicker granulation Axio Biosolutions, based in Bengaluru, has announced that it has received CE Certification from Europe for its next generation adva...

Axio Biosolutions receives CE Certification for next gen wound-care product MaxioCel Axio Biosolutions receives CE Certification for next gen wound-care product MaxioCel 05 February 2021 | News This next-generation advanced wound-care dressing, MaxioCel is based on Bioactive Microfiber Gelling technology that accelerates healing through quicker granulation Axio Biosolutions, based in Bengaluru, has announced that it has received CE Certification from Europe for its next generation adva...

Antimicrobial Wound Dressings Market Size to Reach Revenues of USD 1.5 Billion by 2026 - Arizton CHICAGO, Feb. 2, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this global antimicrobial wound dressings market report. The global antimicrobial wound dressings market is expected to grow at a CAGR of approximately 6% during the period 2020-2026. Key Highlights Offered in the Report: 1. COVID-19 has negatively impacted the antimicrobial woun...